JP2011510013A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510013A5
JP2011510013A5 JP2010543227A JP2010543227A JP2011510013A5 JP 2011510013 A5 JP2011510013 A5 JP 2011510013A5 JP 2010543227 A JP2010543227 A JP 2010543227A JP 2010543227 A JP2010543227 A JP 2010543227A JP 2011510013 A5 JP2011510013 A5 JP 2011510013A5
Authority
JP
Japan
Prior art keywords
independently
compound
alpha
following structure
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010543227A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510013A (ja
Filing date
Publication date
Priority claimed from US12/353,406 external-priority patent/US8809379B2/en
Application filed filed Critical
Publication of JP2011510013A publication Critical patent/JP2011510013A/ja
Publication of JP2011510013A5 publication Critical patent/JP2011510013A5/ja
Withdrawn legal-status Critical Current

Links

JP2010543227A 2008-01-18 2009-01-15 選択的サブタイプアルファ2アドレナリンアゴニスト及びその使用方法 Withdrawn JP2011510013A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2214208P 2008-01-18 2008-01-18
US12/353,406 US8809379B2 (en) 2008-01-18 2009-01-14 Selective subtype alpha 2 adrenergic agents and methods for use thereof
PCT/US2009/031077 WO2009091874A1 (en) 2008-01-18 2009-01-15 Selective subtype alpha 2 adrenergic agents and methods for use thereof

Publications (2)

Publication Number Publication Date
JP2011510013A JP2011510013A (ja) 2011-03-31
JP2011510013A5 true JP2011510013A5 (https=) 2012-03-01

Family

ID=40383664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010543227A Withdrawn JP2011510013A (ja) 2008-01-18 2009-01-15 選択的サブタイプアルファ2アドレナリンアゴニスト及びその使用方法

Country Status (7)

Country Link
US (1) US8809379B2 (https=)
EP (1) EP2249834B1 (https=)
JP (1) JP2011510013A (https=)
AU (1) AU2009206137B2 (https=)
BR (1) BRPI0906928A8 (https=)
CA (1) CA2712269A1 (https=)
WO (1) WO2009091874A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2242753B1 (en) * 2008-01-18 2015-04-08 Allergan, Inc. Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
HUE038366T2 (hu) * 2010-08-16 2018-10-29 Allergan Inc Módszer szabályozó T-sejtek alfa-2B adrenerg receptor agonistákkal való aktiválásához

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212176A (en) 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
KR100639473B1 (ko) * 2005-06-16 2006-10-27 주식회사 삼화양행 압전체의 온도 변화에 따른 주파수 특성을 비선형적으로구하는 방법
CN101346374A (zh) 2005-12-22 2009-01-14 巴斯夫欧洲公司 农业组合物
US7709507B2 (en) 2006-05-17 2010-05-04 Allergan, Inc. Therapeutic fluoroethyl ureas
WO2008123821A1 (en) 2007-03-01 2008-10-16 Albireo Ab 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
WO2008115141A1 (en) 2007-03-19 2008-09-25 Albireo Ab 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
EP2242753B1 (en) * 2008-01-18 2015-04-08 Allergan, Inc. Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
JP5480819B2 (ja) * 2008-01-18 2014-04-23 アラーガン インコーポレイテッド 選択的サブタイプアルファ2アドレナリンアゴニスト及びその使用方法

Similar Documents

Publication Publication Date Title
JP2011509297A5 (https=)
JP2011522774A5 (https=)
JP2007516941A5 (https=)
JP2004517852A5 (https=)
JP2015531764A5 (https=)
AR079542A1 (es) Derivados de benzamida sustituidos, proceso para su preparacion y su uso en el tratamiento de enfermedades mediadas por taars.
JP2005527579A5 (https=)
MX2015015893A (es) 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen.
WO2007016353A3 (en) Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
AR070512A1 (es) Derivados monoamina como antagonistas del receptor de orexina , proceso para la preparacion de dichos compuestos , medicamentos que los contienen y uso de los mismos
CN1486301A (zh) 具有cb1-拮抗活性的4,5-二氢-1h-吡唑衍生物
ECSP12012098A (es) Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos para utilizar los mismos
JP2008526888A5 (https=)
BR112013024312A2 (pt) derivados de amina heterocíclica
MX2009013742A (es) 2-imidazolinas.
HRP20120561T1 (hr) Metil fenilsulfonil piperazin il h benzimidazol kao hidroksitriptaminski ligand
JP2012508275A5 (https=)
EA200970310A1 (ru) Сульфонилпиразольные и сульфонилпиразолиновые производные карбоксамидина как антагонисты 5-ht
JP2016514117A5 (https=)
JP2011510013A5 (https=)
RU2011103759A (ru) Замещенные 6-(1-пиперазинил)-пиридазины в качестве антагонистов 5-нт6 рецептора
JP2007531751A5 (ja) 血管運動症状(vms)の治療のためのノルエピネフリン(ne)およびセロトニン(5−ht)活性およびモノアミン再取り込みの調節物質としてのヘテロサイクリックフェニルプロパン−2−オール誘導体および関連化合物
NZ597498A (en) Cyclopropyl amine derivatives as histamin H3 receptor modulators
JP2011510008A5 (https=)
JP2011510007A5 (https=)